These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10099118)

  • 1. Characterization of intestinal disease associated with human immunodeficiency virus infection and response to antiretroviral therapy.
    Kotler DP
    J Infect Dis; 1999 May; 179 Suppl 3():S454-6. PubMed ID: 10099118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunologic aspects of human immunodeficiency virus infection in the gastrointestinal tract.
    Schneider T; Ullrich R; Zeitz M
    Semin Gastrointest Dis; 1996 Jan; 7(1):19-29. PubMed ID: 8903576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiretroviral therapy on apoptosis markers and morphology in peripheral lymph nodes of HIV-infected individuals.
    Ehrhard S; Wernli M; Kaufmann G; Pantaleo G; Rizzardi GP; Gudat F; Erb P; Battegay M
    Infection; 2008 Mar; 36(2):120-9. PubMed ID: 18379725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis.
    Kotler DP; Shimada T; Snow G; Winson G; Chen W; Zhao M; Inada Y; Clayton F
    AIDS; 1998 Apr; 12(6):597-604. PubMed ID: 9583599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
    Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
    Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mucosal immune system and HIV-1 infection.
    Veazey R; Lackner A
    AIDS Rev; 2003; 5(4):245-52. PubMed ID: 15012003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
    Lascar RM; Lopes AR; Gilson RJ; Dunn C; Johnstone R; Copas A; Reignat S; Webster G; Bertoletti A; Maini MK
    J Infect Dis; 2005 Apr; 191(7):1169-79. PubMed ID: 15747254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
    Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
    J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients.
    Epple HJ; Schneider T; Troeger H; Kunkel D; Allers K; Moos V; Amasheh M; Loddenkemper C; Fromm M; Zeitz M; Schulzke JD
    Gut; 2009 Feb; 58(2):220-7. PubMed ID: 18936106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.
    Mönkemüller KE; Call SA; Lazenby AJ; Wilcox CM
    Am J Gastroenterol; 2000 Feb; 95(2):457-62. PubMed ID: 10685750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.
    Smith KY; Valdez H; Landay A; Spritzler J; Kessler HA; Connick E; Kuritzkes D; Gross B; Francis I; McCune JM; Lederman MM
    J Infect Dis; 2000 Jan; 181(1):141-7. PubMed ID: 10608760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
    De Rossi A; Walker AS; Klein N; De Forni D; King D; Gibb DM
    J Infect Dis; 2002 Aug; 186(3):312-20. PubMed ID: 12134227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy.
    Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN
    J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
    Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
    Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.